EP 1019038 A1 20000719 - PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE AND IRRITABLE BOWEL SYNDROME
Title (en)
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE AND IRRITABLE BOWEL SYNDROME
Title (de)
ARZNEIMITTEL ZUR BEHANDLUNG VON ENTZÜNDLICHEN DARMERKRANKUNGEN UND REIZDARMSYNDROM
Title (fr)
COMPOSITIONS PHARMACEUTIQUES UTILISEES DANS LE TRAITEMENT DE LA MALADIE INTESTINALE INFLAMMATOIRE ET DU SYNDROME DU COLON IRRITABLE
Publication
Application
Priority
- GB 9802933 W 19980929
- GB 9720797 A 19970930
Abstract (en)
[origin: WO9916436A1] Inflammatory bowel disease and irritable bowel syndrome are treated by oral or rectal administration to a patient of an effective amount of a nitric oxide or a nitric oxide donor or physiologically acceptable derivative thereof. Preferably, the active compound is glyceryl trinitrate.
IPC 1-7
IPC 8 full level
A61K 9/00 (2006.01); A61K 9/48 (2006.01); A61K 9/52 (2006.01); A61K 31/21 (2006.01); A61K 31/34 (2006.01); A61P 1/00 (2006.01); A61P 1/04 (2006.01)
CPC (source: EP)
A61K 9/4858 (2013.01); A61K 9/4891 (2013.01); A61K 31/21 (2013.01); A61K 31/34 (2013.01); A61P 1/00 (2017.12); A61P 1/04 (2017.12)
Citation (search report)
See references of WO 9916436A1
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI NL PT SE
DOCDB simple family (publication)
WO 9916436 A1 19990408; AU 9273198 A 19990423; CA 2304516 A1 19990408; EP 1019038 A1 20000719; GB 9720797 D0 19971203; JP 2001517697 A 20011009; ZA 988920 B 19990609
DOCDB simple family (application)
GB 9802933 W 19980929; AU 9273198 A 19980929; CA 2304516 A 19980929; EP 98945401 A 19980929; GB 9720797 A 19970930; JP 2000513572 A 19980929; ZA 988920 A 19980930